Epirubicin Viatris

Epirubicin Viatris is a chemotherapy medication used to treat various types of cancer. This intravenous drug is manufactured by Viatris Limited and is available in the EU market.

Epirubicin Viatris is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it effective for conditions like breast cancer, stomach cancer, and lymphoma. The medication is administered intravenously, targeting cancer cells to slow their growth and spread.

Common effects of Epirubicin Viatris may include nausea, vomiting, and hair loss. Some patients might experience fatigue, fever, or changes in skin color. These effects can vary from person to person and may not affect everyone who uses the medication.

Epirubicin Viatris should be handled with care, as it is a potent chemotherapy drug. It is important to follow the instructions provided by healthcare professionals regarding administration and storage. The medication should be stored at controlled room temperature and protected from light.

Epirubicin Viatris may interact with other medications, including those that affect the heart or immune system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the drug.